Institutional Cluster

KYMR

Kymera Therapeutics, Inc.
MIXED
Impact 4/10
Horizonweeks Processed3mo ago
Institutional cluster: 7 buyers, 4 sellers (mixed)
Actionable Insight ◆ Mixed

The cluster is dominated by passive rebalancing (Fidelity alone accounts for 75% of net buying), which limits the signal's conviction. The active manager additions from AllianceBernstein and Franklin Resources are notable but small relative to the passive flows. Given the 14% historical win rate on KYMR reports and negative alpha, traders should treat this as noise unless a specific pipeline catalyst (e.g., clinical data readout) emerges. Monitor upcoming 13F filings for unwinding of these positions.

DirectionMixed
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
KYMR ▲ +41.50% at T+60d
NEUTRAL call ✓ call won +41.50% · α vs SPY +37.11% · entry $82.96 → $117.39
Entry anchored
Jun 11, 02:34 PM ET
via exchange tick
T+1d
+3.91%
call +3.91% · α +3.37%
$86.21
settled 4mo ago
T+5d
+8.37%
call +8.37% · α +7.93%
$89.90
settled 4mo ago
T+20d
+43.44%
call +43.44% · α +41.55%
$119.00
settled 3mo ago
T+60d
+41.50%
call +41.50% · α +37.11%
$117.39
settled 24d ago

Executive Summary

A mixed institutional cluster in Kymera Therapeutics for Q4 2025 shows 7 buyers adding $485.7M in net new positions, dominated by passive/index funds (Fidelity, BofA, Wells Fargo, Invesco) alongside two active managers (AllianceBernstein new at $74.1M, Franklin Resources doubling to $27.6M). Four sellers trimmed modestly, led by quant fund Two Sigma (-$3.7M) and Massachusetts Financial Services (-$2.1M). The heavy passive buying likely reflects index rebalancing rather than a fundamental catalyst, while the active manager additions suggest selective conviction in Kymera's protein degradation pipeline.

Key Financial Metrics

Direction
mixed
Buy Value
$837.3M
Sell Value
$6.9M
Net Flow
$478.7M

Institutional Positions

Net institutional flow: $478.7M

▲ Buyers (7)

InstitutionActionChangePosition ValueValue Δ
FidelityADD+51.9%$694.7M$361.9M
AlliancebernsteinNEW—$74.1M$74.1M
Franklin ResourcesDOUBLED+1019.9%$27.6M$25.8M
BofAADD+82%$26.4M$15.8M
InvescoADD+46.3%$9.1M$4.6M
Wells FargoDOUBLED+107.4%$5.2M$3.4M
Mirae Asset Global InvestmentsADD+26.5%$272.0K$116.0K

▼ Sellers (4)

InstitutionActionChangePrev ValueValue Δ
Two SigmaTRIM-38.2%$24.3M-$3.7M
Massachusetts Financial ServicTRIM-33.5%$24.6M-$2.1M
Ameriprise FinancialNEAR_EXIT-85.8%$1.4M-$1.1M
Morgan StanleyTRIM-27.5%$21.4M-$62.1K

Key Facts

  • 7 buyers added $485.7M in net new positions; 4 sellers reduced by $6.9M
  • Fidelity added 3.05M shares (+51.9%), now holding $694.7M — the dominant buyer
  • AllianceBernstein initiated a new $74.1M position, the largest active-manager entry
  • Franklin Resources nearly 11x'd its stake (+1019.9%) to $27.6M
  • Two Sigma trimmed 38.2% of its position (-$3.7M), the largest seller by dollar value
  • Morgan Stanley trimmed only 27.5% (-$62K), a negligible reduction
  • 5 of 7 buyers are mega-passive/index funds; only 2 are active asset managers
  • Historical T+20 win rate on KYMR reports is 14% with avg alpha -9.46% vs SPY

Financial Impact

Net institutional buying of $478.7M ($485.7M bought vs $6.9M sold) across 11 filers

institutional ownershipfloatvaluation

Risk Factors

  • 45-day 13F reporting lag means positions may already be unwound
  • Passive-dominated cluster provides weak directional signal
  • Historical KYMR reports show negative alpha at T+20 (-9.46% avg vs SPY)
  • Two Sigma's trim suggests quantitative models are reducing exposure

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (30 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-KYMR-2025-Q4
30 reports for KYMR
Performance horizon
67% Hit rate 8 of 12 directional calls best @ T+60▲ +60.99%Jun 8, 2026
Filters
Rows
Reports for KYMR — sortable, filterable
TypeNow
Aug 5, 2026
8w ago
8-K
BULLISH ★ 6/10
$105.48 $118.63▲ +12.47%▲ +13.07%—
Jul 8, 2026
12w ago
Insider Cluster
BEARISH ★ 5/10
$114.16 $105.48▲ +7.60%▲ +10.88%—
Jul 2, 2026
13w ago
Insider Cluster
BEARISH ★ 6/10
$113.51 $107.01▲ +5.73%▲ +5.31%—
Jul 2, 2026
13w ago
Insider Cluster
BEARISH ★ 5/10
$113.51 $107.01▲ +5.73%▲ +5.31%—
Jun 30, 2026
13w ago
144
BEARISH ★ 4/10
$114.20 $105.25▲ +7.84%▲ +5.65%—
Jun 29, 2026
13w ago
144
NEUTRAL ★ 4/10
$114.67 $110.05▼ −4.03%▼ −3.00%—
Jun 26, 2026
13w ago
Insider Cluster
BEARISH ★ 6/10
$109.32 $110.57▼ −1.14%▼ −1.42%—
Jun 26, 2026
13w ago
144
BEARISH ★ 6/10
$109.32 $110.57▼ −1.14%▼ −1.42%—
Jun 26, 2026
13w ago
144
BEARISH ★ 6/10
$109.32 $110.57▼ −1.14%▼ −1.42%—
Jun 24, 2026
14w ago
144
NEUTRAL ★ 2/10
$116.46 $110.38▼ −5.22%▼ −5.75%—
Showing 10 of 30

US Market Status

Market Closed — Opens Mon (64h 59m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 11, 2026